Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083048250> ?p ?o ?g. }
- W2083048250 endingPage "e30898" @default.
- W2083048250 startingPage "e30898" @default.
- W2083048250 abstract "The inability of seasonal influenza vaccines to effectively protect against infection with antigenically drifted viruses or newly emerging pandemic viruses underlines the need for development of cross-reactive influenza vaccines that induce immunity against a variety of virus subtypes. Therefore, potential cross-protective vaccines, e.g., whole inactivated virus (WIV) vaccine, that can target conserved internal antigens such as the nucleoprotein (NP) and/or matrix protein (M1) need to be explored.In the current study we show that a WIV vaccine, through induction of cross-protective cytotoxic T lymphocytes (CTLs), protects mice from heterosubtypic infection. This protection was abrogated after depletion of CD8+ cells in vaccinated mice, indicating that CTLs were the primary mediators of protection. Previously, we have shown that different procedures used for virus inactivation influence optimal activation of CTLs by WIV, most likely by affecting the membrane fusion properties of the virus. Specifically, inactivation with formalin (FA) severely compromises fusion activity of the virus, while inactivation with β-propiolactone (BPL) preserves fusion activity. Here, we demonstrate that vaccination of mice with BPL-inactivated H5N1 WIV vaccine induces solid protection from lethal heterosubtypic H1N1 challenge. By contrast, vaccination with FA-inactivated WIV, while preventing death after lethal challenge, failed to protect against development of disease and severe body weight loss. Vaccination with BPL-inactivated WIV, compared to FA-inactivated WIV, induced higher levels of specific CD8+ T cells in blood, spleen and lungs, and a higher production of granzyme B in the lungs upon H1N1 virus challenge.The results underline the potential use of WIV as a cross-protective influenza vaccine candidate. However, careful choice of the virus inactivation procedure is important to retain membrane fusion activity and full immunogenicity of the vaccine." @default.
- W2083048250 created "2016-06-24" @default.
- W2083048250 creator A5012996455 @default.
- W2083048250 creator A5025153030 @default.
- W2083048250 creator A5044860916 @default.
- W2083048250 creator A5046316209 @default.
- W2083048250 creator A5047921978 @default.
- W2083048250 creator A5053871610 @default.
- W2083048250 creator A5059815378 @default.
- W2083048250 creator A5065346505 @default.
- W2083048250 date "2012-01-27" @default.
- W2083048250 modified "2023-10-18" @default.
- W2083048250 title "Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity" @default.
- W2083048250 cites W1824220324 @default.
- W2083048250 cites W1901508837 @default.
- W2083048250 cites W1969144034 @default.
- W2083048250 cites W1985838249 @default.
- W2083048250 cites W1988255598 @default.
- W2083048250 cites W1989938774 @default.
- W2083048250 cites W1994391392 @default.
- W2083048250 cites W1994907646 @default.
- W2083048250 cites W1995171974 @default.
- W2083048250 cites W2010820891 @default.
- W2083048250 cites W2018424830 @default.
- W2083048250 cites W2021199802 @default.
- W2083048250 cites W2023545435 @default.
- W2083048250 cites W2028752713 @default.
- W2083048250 cites W2042777577 @default.
- W2083048250 cites W2047885035 @default.
- W2083048250 cites W2064773757 @default.
- W2083048250 cites W2070215035 @default.
- W2083048250 cites W2073367505 @default.
- W2083048250 cites W2084480062 @default.
- W2083048250 cites W2089047399 @default.
- W2083048250 cites W2090214720 @default.
- W2083048250 cites W2091459248 @default.
- W2083048250 cites W2099576461 @default.
- W2083048250 cites W2102990388 @default.
- W2083048250 cites W2106367537 @default.
- W2083048250 cites W2117655206 @default.
- W2083048250 cites W2127840828 @default.
- W2083048250 cites W2128313765 @default.
- W2083048250 cites W2128825948 @default.
- W2083048250 cites W2129973151 @default.
- W2083048250 cites W2134250807 @default.
- W2083048250 cites W2135511012 @default.
- W2083048250 cites W2137594178 @default.
- W2083048250 cites W2140363155 @default.
- W2083048250 cites W2144597286 @default.
- W2083048250 cites W2146806799 @default.
- W2083048250 cites W2149729472 @default.
- W2083048250 cites W2152367839 @default.
- W2083048250 cites W2161001526 @default.
- W2083048250 cites W2163624071 @default.
- W2083048250 cites W2169905609 @default.
- W2083048250 cites W2170287675 @default.
- W2083048250 cites W2318325499 @default.
- W2083048250 cites W4205978945 @default.
- W2083048250 doi "https://doi.org/10.1371/journal.pone.0030898" @default.
- W2083048250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3267744" @default.
- W2083048250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22303469" @default.
- W2083048250 hasPublicationYear "2012" @default.
- W2083048250 type Work @default.
- W2083048250 sameAs 2083048250 @default.
- W2083048250 citedByCount "70" @default.
- W2083048250 countsByYear W20830482502012 @default.
- W2083048250 countsByYear W20830482502013 @default.
- W2083048250 countsByYear W20830482502014 @default.
- W2083048250 countsByYear W20830482502015 @default.
- W2083048250 countsByYear W20830482502016 @default.
- W2083048250 countsByYear W20830482502017 @default.
- W2083048250 countsByYear W20830482502018 @default.
- W2083048250 countsByYear W20830482502019 @default.
- W2083048250 countsByYear W20830482502020 @default.
- W2083048250 countsByYear W20830482502021 @default.
- W2083048250 countsByYear W20830482502022 @default.
- W2083048250 countsByYear W20830482502023 @default.
- W2083048250 crossrefType "journal-article" @default.
- W2083048250 hasAuthorship W2083048250A5012996455 @default.
- W2083048250 hasAuthorship W2083048250A5025153030 @default.
- W2083048250 hasAuthorship W2083048250A5044860916 @default.
- W2083048250 hasAuthorship W2083048250A5046316209 @default.
- W2083048250 hasAuthorship W2083048250A5047921978 @default.
- W2083048250 hasAuthorship W2083048250A5053871610 @default.
- W2083048250 hasAuthorship W2083048250A5059815378 @default.
- W2083048250 hasAuthorship W2083048250A5065346505 @default.
- W2083048250 hasBestOaLocation W20830482501 @default.
- W2083048250 hasConcept C147483822 @default.
- W2083048250 hasConcept C154317977 @default.
- W2083048250 hasConcept C159047783 @default.
- W2083048250 hasConcept C202751555 @default.
- W2083048250 hasConcept C203014093 @default.
- W2083048250 hasConcept C22070199 @default.
- W2083048250 hasConcept C2522874641 @default.
- W2083048250 hasConcept C2777546802 @default.
- W2083048250 hasConcept C2779341262 @default.
- W2083048250 hasConcept C2780868878 @default.
- W2083048250 hasConcept C519248777 @default.